Alpha Teknova (NASDAQ:TKNO – Get Rating) is set to release its earnings data after the market closes on Wednesday, March 15th. Persons that wish to listen to the company’s conference call can do so using this link.
Alpha Teknova Price Performance
NASDAQ TKNO opened at $5.04 on Wednesday. The company has a 50 day simple moving average of $5.67 and a 200-day simple moving average of $4.79. The company has a debt-to-equity ratio of 0.15, a current ratio of 5.68 and a quick ratio of 4.85. The firm has a market capitalization of $141.57 million, a price-to-earnings ratio of -3.73 and a beta of 0.33. Alpha Teknova has a 52-week low of $3.02 and a 52-week high of $18.34.
Analyst Upgrades and Downgrades
A number of research firms recently commented on TKNO. Cowen dropped their price objective on Alpha Teknova from $13.00 to $8.00 in a report on Thursday, November 10th. Stephens dropped their price objective on Alpha Teknova to $12.00 in a report on Wednesday, November 16th. Finally, Cowen lowered their price target on Alpha Teknova from $13.00 to $8.00 in a report on Thursday, November 10th.
Institutional Inflows and Outflows
About Alpha Teknova
Alpha Teknova, Inc provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
- Get a free copy of the StockNews.com research report on Alpha Teknova (TKNO)
- Under-the-Radar Azul SA Takes Flight on Robust Travel Demand
- Market Gets “Powelled”: S&P 500 Confirms Resistance
- Ulta Insiders Hold Tight: Sell-Siders Buy
- Rivian Plummets, But Is This 2023’s Greatest Buying Opportunity?
- Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.